Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
PUT
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $62.4K | ﹤0.01% |
1,200
-100
| -8% | -$4.94K |
|
11452
PUT
Unisys
UIS
$217M
| $62.4K | ﹤0.01% |
11,100
-24,500
| -69% | -$104K |
|
11453
PUT
NMI Holdings
NMIH
$3.36B
| $62.3K | ﹤0.01% |
2,100
-700
| -25% | -$19.5K |
|
11454
CALL
Beyond Air
XAIR
$3.86M
| $62.3K | ﹤0.01% |
80
+3
| +4% | +$2.34K |
|
11455
CALL
WidePoint Corp
WYY
$114M
| $62.2K | ﹤0.01% |
26,800
+24,800
| +1,240% | +$44.6K |
|
11456
PUT
Monte Rosa Therapeutics
GLUE
$1.35B
| $62.1K | ﹤0.01% |
+11,000
| New | +$43.2K |
|
|
FNA
11457
PUT
DELISTED
Paragon 28, Inc.
FNA
| $62.1K | ﹤0.01% |
5,000
+400
| +9% | +$4.23K |
|
11458
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $62.1K | ﹤0.01% |
600
-2,400
| -80% | -$231K |
|
11459
PUT
Phathom Pharmaceuticals
PHAT
$692M
| $62.1K | ﹤0.01% |
6,800
+4,000
| +143% | +$34.5K |
|
11460
PUT
Schwab US Large- Cap ETF
SCHX
$74.6B
| $62K | ﹤0.01% |
3,300
+900
| +38% | +$15.8K |
|
11461
PUT
Arbutus Biopharma
ABUS
$915M
| $62K | ﹤0.01% |
24,800
+1,600
| +7% | +$3.13K |
|
|
NGM
11462
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $62K | ﹤0.01% |
72,174
-91,972
| -56% | -$80.8K |
|
11463
PUT
Oppenheimer Holdings
OPY
$1.2B
| $62K | ﹤0.01% |
1,500
-18,400
| -92% | -$704K |
|
11464
CALL
AdaptHealth
AHCO
$759M
| $62K | ﹤0.01% |
8,500
-37,300
| -81% | -$294K |
|
11465
CALL
VanEck High Yield Muni ETF
HYD
$4.4B
| $62K | ﹤0.01% |
1,200
-200
| -14% | -$9.91K |
|
11466
PUT
AMES National
ATLO
$277M
| $61.9K | ﹤0.01% |
2,900
+2,700
| +1,350% | +$49.4K |
|
11467
PUT
Arena Group
AREN
$83.8M
| $61.9K | ﹤0.01% |
26,000
+17,400
| +202% | +$57.4K |
|
11468
PUT
Global X SuperDividend US ETF
DIV
$783M
| $61.8K | ﹤0.01% |
3,600
-7,000
| -66% | -$114K |
|
11469
PharmaCyte Biotech
PMCB
$6.34M
| $61.8K | ﹤0.01% |
28,618
-6,766
| -19% | -$14.7K |
|
11470
Broadwind
BWEN
$109M
| $61.8K | ﹤0.01% |
22,313
+14,395
| +182% | +$38K |
|
|
PTVE
11471
CALL
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $61.7K | ﹤0.01% |
4,500
+3,400
| +309% | +$35.8K |
|
11472
PUT
VanEck Oil Refiners ETF
CRAK
$253M
| $61.6K | ﹤0.01% |
+1,800
| New | +$61.1K |
|
11473
PUT
iShares International Select Dividend ETF
IDV
$8.57B
| $61.6K | ﹤0.01% |
2,200
+2,000
| +1,000% | +$52.2K |
|
11474
PUT
Global X Cybersecurity ETF
BUG
$1.46B
| $61.6K | ﹤0.01% |
2,100
-5,600
| -73% | -$144K |
|
11475
Fortis
FTS
$28.7B
| $61.4K | ﹤0.01% |
1,494
-157,403
| -99% | -$6.35M |
|
Similar funds
Citadel Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,625 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Citadel Advisors opened 1,585 new positions and closed 1,625 in Q4 2023.
- Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.